Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
426 Ergebnisse
| FD1V2V | Vertex Pharmaceuticals Inc./OS/Call [340]/SOC | - | - | 340,000 | call | Vertex Pharmaceuticals Inc. | - | - | - | - | - | 15.01.2027 | 0,100 | Société Générale | ||
| GU1LER | Vertex Pharmaceuticals Inc./OS/Call [350]/GOLDS | - | - | 350,000 | call | Vertex Pharmaceuticals Inc. | - | 46,726 % | 0,888 | -0,074 | 2,853 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| GU1LEW | Vertex Pharmaceuticals Inc./OS/Call [350]/GOLDS | - | - | 350,000 | call | Vertex Pharmaceuticals Inc. | - | 53,878 % | 0,947 | -0,082 | 3,330 | 18.09.2026 | 0,100 | Goldman Sachs | ||
| GU1LKH | Vertex Pharmaceuticals Inc./OS/Call [350]/GOLDS | - | - | 350,000 | call | Vertex Pharmaceuticals Inc. | - | 45,834 % | 0,903 | -0,073 | 2,984 | 18.12.2026 | 0,100 | Goldman Sachs | ||
| FD1ZF5 | Vertex Pharmaceuticals Inc./OS/Call [350]/SOC | - | - | 350,000 | call | Vertex Pharmaceuticals Inc. | - | 48,109 % | 0,863 | -0,073 | 2,626 | 19.03.2027 | 0,100 | Société Générale | ||
| FD1V2W | Vertex Pharmaceuticals Inc./OS/Call [360]/SOC | - | - | 360,000 | call | Vertex Pharmaceuticals Inc. | - | 47,308 % | 0,868 | -0,081 | 2,936 | 15.01.2027 | 0,100 | Société Générale | ||
| MM215M |  | Vertex Pharmaceuticals Inc./OS/Call [375]/MS | - | - | 375,000 | call | Vertex Pharmaceuticals Inc. | - | 49,690 % | 0,843 | -0,010 | 3,154 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MM215N | | Vertex Pharmaceuticals Inc./OS/Call [375]/MS | - | - | 375,000 | call | Vertex Pharmaceuticals Inc. | - | 48,850 % | 0,805 | -0,008 | 2,539 | 17.06.2027 | 0,010 | Morgan Stanley | |
| GW4K28 | Vertex Pharmaceuticals Inc./OS/Call [380]/GOLDS | - | - | 380,000 | call | Vertex Pharmaceuticals Inc. | - | 42,381 % | 0,815 | -0,068 | 2,766 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GW52A5 | Vertex Pharmaceuticals Inc./OS/Call [380]/GOLDS | - | - | 380,000 | call | Vertex Pharmaceuticals Inc. | - | 43,576 % | 0,825 | -0,077 | 3,002 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GW5YD6 | Vertex Pharmaceuticals Inc./OS/Call [380]/GOLDS | - | - | 380,000 | call | Vertex Pharmaceuticals Inc. | - | 43,191 % | 0,845 | -0,083 | 3,279 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| FD1V2X | Vertex Pharmaceuticals Inc./OS/Call [380]/SOC | - | - | 380,000 | call | Vertex Pharmaceuticals Inc. | - | 45,269 % | 0,838 | -0,087 | 3,203 | 15.01.2027 | 0,100 | Société Générale | ||
| FD1YTL | Vertex Pharmaceuticals Inc./OS/Call [380]/SOC | - | - | 380,000 | call | Vertex Pharmaceuticals Inc. | - | - | - | - | - | 18.09.2026 | 0,100 | Société Générale | ||
| FE4XZ0 | Vertex Pharmaceuticals Inc./OS/Call [380]/SOC | - | - | 380,000 | call | Vertex Pharmaceuticals Inc. | - | 44,094 % | 0,854 | -0,087 | 3,396 | 18.12.2026 | 0,100 | Société Générale | ||
| FE58HF | Vertex Pharmaceuticals Inc./OS/Call [380]/SOC | - | - | 380,000 | call | Vertex Pharmaceuticals Inc. | - | 45,990 % | 0,817 | -0,081 | 2,919 | 19.03.2027 | 0,100 | Société Générale | ||
| FE58UV | Vertex Pharmaceuticals Inc./OS/Call [380]/SOC | - | - | 380,000 | call | Vertex Pharmaceuticals Inc. | - | 44,521 % | 0,808 | -0,071 | 2,699 | 17.06.2027 | 0,100 | Société Générale | ||
| FE58VC | Vertex Pharmaceuticals Inc./OS/Call [380]/SOC | - | - | 380,000 | call | Vertex Pharmaceuticals Inc. | - | 44,192 % | 0,794 | -0,057 | 2,325 | 21.01.2028 | 0,100 | Société Générale | ||
| GJ8XFZ | Vertex Pharmaceuticals Inc./OS/Call [400]/GOLDS | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 40,661 % | 0,821 | -0,091 | 3,826 | 18.12.2026 | 0,100 | Goldman Sachs | ||
| GJ9UEE | Vertex Pharmaceuticals Inc./OS/Call [400]/GOLDS | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 41,598 % | 0,807 | -0,089 | 3,587 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| GV70P1 | Vertex Pharmaceuticals Inc./OS/Call [400]/GOLDS | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 43,599 % | 0,884 | -0,113 | 4,716 | 18.09.2026 | 0,100 | Goldman Sachs | ||
| GV87SP | Vertex Pharmaceuticals Inc./OS/Call [400]/GOLDS | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 41,436 % | 0,780 | -0,072 | 2,950 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GU3QTR | Vertex Pharmaceuticals Inc./OS/Call [400]/GOLDS | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 41,680 % | 0,806 | -0,089 | 3,585 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| GU3QWZ | Vertex Pharmaceuticals Inc./OS/Call [400]/GOLDS | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 41,343 % | 0,781 | -0,071 | 2,954 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GW0KKU | Vertex Pharmaceuticals Inc./OS/Call [400]/GOLDS | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 43,866 % | 0,767 | -0,059 | 2,416 | 21.01.2028 | 0,100 | Goldman Sachs | ||
| GW2MV9 | Vertex Pharmaceuticals Inc./OS/Call [400]/GOLDS | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 42,347 % | 0,788 | -0,082 | 3,234 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| JU31UG | Vertex Pharmaceuticals Inc./OS/Call [400]/JPM | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 46,222 % | 0,872 | -0,124 | 4,611 | 18.09.2026 | 0,100 | JP Morgan | ||
| JU22GB | Vertex Pharmaceuticals Inc./OS/Call [400]/JPM | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 45,013 % | 0,795 | -0,096 | 3,432 | 15.01.2027 | 0,100 | JP Morgan | ||
| JU3FQ5 | Vertex Pharmaceuticals Inc./OS/Call [400]/JPM | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 43,702 % | 0,809 | -0,098 | 3,680 | 18.12.2026 | 0,100 | JP Morgan | ||
| MM215P | | Vertex Pharmaceuticals Inc./OS/Call [400]/MS | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 47,190 % | 0,768 | -0,008 | 2,729 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MM215Q | | Vertex Pharmaceuticals Inc./OS/Call [400]/MS | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 46,222 % | 0,801 | -0,010 | 3,565 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MM5JNX | | Vertex Pharmaceuticals Inc./OS/Call [400]/MS | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 53,778 % | 0,843 | -0,016 | 4,294 | 18.09.2026 | 0,010 | Morgan Stanley | |
| MR15AY | | Vertex Pharmaceuticals Inc./OS/Call [400]/MS | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 48,120 % | 0,773 | -0,009 | 2,998 | 19.03.2027 | 0,010 | Morgan Stanley | |
| FA53J8 | Vertex Pharmaceuticals Inc./OS/Call [400]/SOC | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 42,479 % | 0,814 | -0,095 | 3,734 | 18.12.2026 | 0,100 | Société Générale | ||
| FD1V2Y | Vertex Pharmaceuticals Inc./OS/Call [400]/SOC | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 44,156 % | 0,797 | -0,095 | 3,473 | 15.01.2027 | 0,100 | Société Générale | ||
| FD1ZF6 | Vertex Pharmaceuticals Inc./OS/Call [400]/SOC | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 44,645 % | 0,782 | -0,086 | 3,133 | 19.03.2027 | 0,100 | Société Générale | ||
| FE58HB | Vertex Pharmaceuticals Inc./OS/Call [400]/SOC | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 46,154 % | 0,873 | -0,124 | 4,604 | 18.09.2026 | 0,100 | Société Générale | ||
| FE58U4 | Vertex Pharmaceuticals Inc./OS/Call [400]/SOC | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 43,857 % | 0,767 | -0,066 | 2,639 | 17.09.2027 | 0,100 | Société Générale | ||
| FE58U8 | Vertex Pharmaceuticals Inc./OS/Call [400]/SOC | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 43,370 % | 0,767 | -0,061 | 2,488 | 17.12.2027 | 0,100 | Société Générale | ||
| FE58UW | Vertex Pharmaceuticals Inc./OS/Call [400]/SOC | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 43,552 % | 0,776 | -0,075 | 2,863 | 17.06.2027 | 0,100 | Société Générale | ||
| FE58VD | Vertex Pharmaceuticals Inc./OS/Call [400]/SOC | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 43,199 % | 0,768 | -0,059 | 2,438 | 21.01.2028 | 0,100 | Société Générale | ||
| VH628B | | Vertex Pharmaceuticals Inc./OS/Call [400]/VONT | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 44,621 % | 0,796 | -0,096 | 3,452 | 15.01.2027 | 0,100 | Vontobel | |
| VY37YC | | Vertex Pharmaceuticals Inc./OS/Call [400]/VONT | - | - | 400,000 | call | Vertex Pharmaceuticals Inc. | - | 42,034 % | 0,815 | -0,094 | 3,760 | 18.12.2026 | 0,100 | Vontobel | |
| JU31UE | Vertex Pharmaceuticals Inc./OS/Call [410]/JPM | - | - | 410,000 | call | Vertex Pharmaceuticals Inc. | - | 45,387 % | 0,846 | -0,136 | 4,928 | 18.09.2026 | 0,100 | JP Morgan | ||
| JU26QC | Vertex Pharmaceuticals Inc./OS/Call [410]/JPM | - | - | 410,000 | call | Vertex Pharmaceuticals Inc. | - | 43,065 % | 0,786 | -0,102 | 3,851 | 18.12.2026 | 0,100 | JP Morgan | ||
| JU355A | Vertex Pharmaceuticals Inc./OS/Call [410]/JPM | - | - | 410,000 | call | Vertex Pharmaceuticals Inc. | - | 44,541 % | 0,773 | -0,100 | 3,569 | 15.01.2027 | 0,100 | JP Morgan | ||
| GW3T1P | Vertex Pharmaceuticals Inc./OS/Call [420]/GOLDS | - | - | 420,000 | call | Vertex Pharmaceuticals Inc. | - | 41,286 % | 0,748 | -0,086 | 3,479 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GW3T4G | Vertex Pharmaceuticals Inc./OS/Call [420]/GOLDS | - | - | 420,000 | call | Vertex Pharmaceuticals Inc. | - | 40,542 % | 0,744 | -0,075 | 3,139 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GW3T4K | Vertex Pharmaceuticals Inc./OS/Call [420]/GOLDS | - | - | 420,000 | call | Vertex Pharmaceuticals Inc. | - | 40,661 % | 0,760 | -0,096 | 3,901 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| JU34AE | Vertex Pharmaceuticals Inc./OS/Call [420]/JPM | - | - | 420,000 | call | Vertex Pharmaceuticals Inc. | - | 44,507 % | 0,817 | -0,147 | 5,267 | 18.09.2026 | 0,100 | JP Morgan | ||
| JU355E | Vertex Pharmaceuticals Inc./OS/Call [420]/JPM | - | - | 420,000 | call | Vertex Pharmaceuticals Inc. | - | 43,984 % | 0,751 | -0,103 | 3,711 | 15.01.2027 | 0,100 | JP Morgan |